微生物组和胰腺癌:是时候考虑化疗了
Juliana de Castilhos1,2, Katharina Tillmanns1,2, Jana Blessing1,2
1Translational Microbiome Research, Internal Medicine I and M3 Research Center, University Hospital Tuebingen, Tübingen, Germany.
Gut microbes
|July 18, 2024
概括
肠道微生物组会影响胰腺癌的治疗. 了解这些微生物相互作用可以提高化疗的有效性,并导致胰腺管道腺癌 (PDAC) 的个性化疗法.
科学领域:
- 在瘤学瘤学.
- 微生物组研究 微生物组研究
- 癌症生物学 癌症生物学
背景情况:
- 胰腺管腺癌 (PDAC) 是由于复杂的瘤生物学和治疗耐药性而具有不良结果的侵略性.
- 在PDAC中的瘤微环境是密集的,层状的和免疫抑制的,阻碍了标准疗法.
- 微生物组在PDAC治疗疗效中的作用仍然是积极研究的领域.
研究的目的:
- 综合审查微生物组在调节化疗疗效和PDAC的结果中的动态作用.
- 探索微生物群对药物代谢,耐药性和瘤免疫微环境的影响.
- 确定知识差距,并讨论针对个性化PDAC治疗的潜在基于微生物组的干预措施.
主要方法:
- 文献综述综合了最近关于微生物组和PDAC的研究.
- 讨论影响药物作用和免疫反应的特定细菌物种和酶.
- 探索先进的方法,如人工智能,低生物质微生物组分析和有机体模型.
主要成果:
- 微生物组通过药物代谢和耐药性调节显著影响PDAC中的化疗疗效.
- 特定的微生物元素和酶可以影响药物作用和瘤免疫微观环境.
- 新兴技术为微生物与癌细胞相互作用提供了新的见解.
结论:
- 微生物组在PDAC化疗反应和患者的治疗结果中发挥着关键作用.
- 准微生物组为传统PDAC治疗提供了一个有前途的辅助疗法.
- 需要进一步的研究来阐明机制,并开发针对PDAC的个性化,微生物组知情的治疗策略.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:29Chronic Pancreatitis II: Collaborative Care
82
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
82
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158